Pressure BioSciences, Inc., a life sciences company, engages in the research, development, and commercialization of pressure cycling technology (PCT) that uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. The company offers Barocycler instrumentation, which includes Barocycler NEP3229 that is capable of processing up to three samples simultaneously using its single-use PULSE Tubes; and Barocycler NEP2320, which processes one sample at a time and works on compressed air. It also provides consumable products comprising PULSE Tubes...
Today Pressure BioSciences Incorporated announced that it has added a new member to its senior executive management team; Vice President of Sales. Matthew B. Potter will now oversee Pressure Biosciences’ seven US-based, regional sales directors and will be responsible for driving the Company’s commercialization of their novel and patented pressure cycling technology (PCT) product line. Matthew Potter brings just short of twenty years of sales and management experience in both the pharmaceutical and biotechnology fields.
Potter has been a Sales Manager at Pharmacia Biotech; National S...
Founded in 1978, Pressure Biosciences (NASDAQ: PBIO) began significant operations in 1986 and went public 10 years later in 1996, under its former name, Boston Biomedica, Inc. Today the company holds 13 U.S. patents and four foreign patents for applications of its Pressure Cycling Technology (PCT), used in the healthcare field for genomics, proteomics and nucleic acid testing with the ability to rupture cells to release significantly more proteins in fatty tissue.
The company’s PCT Sample Preparation System (PCT SPS) allows for the safe, rapid and reproducible extraction of DNA, RNA,...
Dutton Associates recently rated Pressure BioSciences, Inc. (NASDAQ: PBIO) as a “Speculative Strong Buy,” pricing the 12-month target at $10 per share. The research report commends the company on its “unique and superior technology” applicable to a variety of areas in the life-sciences field.
As Pressure BioSciences utilizes its expanded sales force, Dutton said it expects sales to increase in the upcoming quarters of 2008. The company’s Commercialization Plan called for the addition of seven full-time sales directors to help the company spread its regional coverage.
According to the most recent National Health and Nutrition Examination survey, roughly two-thirds of the adults in the United States are overweight, slowly closing the gap between themselves and the one-third of Americans considered obese. Analyzing the protein from lipid-rich tissues helps researchers understand the disease that kills about 300,000 people each year in the U.S. Additionally, obesity is linked to heart disease, stroke, cancer and diabetes.
PressureBiosciences, Inc. (NASDAQ: PBIO) developed Pressure Cycling Technology (PCT) which uses cycles of hydrostatic pressure, as...
QualityStocks.net Featured Companies
- In this discussion we will present articles highlighting the companies we are currently featuring and believe to have the potential to grow rapidly in
Data powered by QuoteMedia.
All Rights Reserved.
Data delayed 15 to 20 minutes unless otherwise indicated.
Terms of Use.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.
PBIO
About Pressure BioSciences Inc.
- Answers.com
